olprinone

Known as: 1,2-dihydro-6-methyl-2-oxo-5-(imidazo(1,2-a)pyridin-6-yl)-3-pyridinecarbonitrile 
 

Topic mentions per year

Topic mentions per year

1997-2017
051019972017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Splanchnic artery occlusion (SAO) shock is a severe form of circulatory shock produced by ischemia and reperfusion of the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
BACKGROUND Olprinone hydrochloride is a newly developed compound that selectively inhibits PDE type III and is characterized by… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
2008
2008
Olprinone, an inhibitor of cyclic nucleotide phosphodiesterase III, inhibited an increase in intracellular Ca(2+) concentrations… (More)
Is this relevant?
2007
2007
OBJECTIVE Renal ischemic reperfusion injury (IRI) is unavoidable and is still one of the major problems in renal transplantation… (More)
Is this relevant?
2006
2006
We investigated the effect of olprinone on canine myocardial pump function and myocardial damage after ischemia-reperfusion… (More)
Is this relevant?
2005
2005
Activated leukocytes are implicated in development of ischemia/reperfusion (I/R)-induced organ injuries. Phosphodiesterase 3… (More)
Is this relevant?
2003
2003
Cerebral blood flow (CBF) is reduced in heart failure (HF). For the treatment of acute HF, a phosphodiesterase-3 inhibitor… (More)
Is this relevant?
2000
2000
OBJECTIVE To measure the hepatic venous oxygen saturation in patients after cardiac surgery and to compare the effects of… (More)
Is this relevant?
1999
1999
The effect of topical administration of phosphodiesterase (PDE) 3 inhibitors on the airway is not clear. In order to examine the… (More)
Is this relevant?
1997
1997
Phosphodiesterase inhibitor (PDEI) has been accepted as an inodilator with positive inotoropic and vasodilating actions. Recently… (More)
Is this relevant?